Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) is a secreted, N-linked glycoprotein enzyme of the metallophosphodiesterase family, closely related to human acid sphingomyelinase (aSMase) but lacking sphingomyelinase activity. Instead, SMPDL3A displays strong nucleotide phosphodiesterase activity, hydrolyzing nucleotide di- and triphosphates—including modified nucleotides such as CDP-choline, CDP-ethanolamine, and ADP-ribose—at acidic and neutral pH. The enzyme is upregulated in human macrophages by cholesterol loading, liver X receptor ligands, and cyclic AMP, potentially reducing extracellular levels of pro-inflammatory nucleotides and supporting anti-inflammatory signaling in atherosclerotic lesions. Structural studies reveal a binuclear Zn(2+)-dependent catalytic site similar to other acid sphingomyelinase family members, but with unique substrate preferences. SMPDL3A is also upregulated in certain human tumors and may serve as a functional link between lipid metabolism, nucleotide signaling, and inflammation.
Catalyzes the hydrolysis of nucleotide di- and triphosphates, such as cytidine 5'-diphosphocholine (CDP-choline), cytidine diphosphate ethanolamine, and ADP-ribose, but not sphingomyelin
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A).